Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

OncoAlert and ecancer weekly roundup for February 01 - 06, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
9 Feb 2021

Latest in EGFR-positive NSCLC with exon 20 insertion mutations

Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo, Dr Enriqueta Felip
Latest in EGFR-positive NSCLC with exon 20 insertion mutations ( Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo, Dr Enriqueta Felip )
9 Feb 2021

WCLC 2020 overview

Dr Luis Raez - Memorial Healthcare System, Hollywood, FL, USA
WCLC 2020 overview ( Dr Luis Raez - Memorial Healthcare System, Hollywood, FL, USA )
5 Feb 2021

Emergence of PARP inhibitors in prostate cancer

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK
Emergence of PARP inhibitors in prostate cancer ( Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK )
5 Feb 2021

OncoAlert and ecancer weekly roundup for January 25 - 31, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for January 25 - 31, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
4 Feb 2021

Role of PARP inhibitors in treating advanced prostate cancer

Noam Shabani - Dana-Farber Cancer Institute, Boston, USA
Role of PARP inhibitors in treating advanced prostate cancer ( Noam Shabani - Dana-Farber Cancer Institute, Boston, USA )
3 Feb 2021

WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC

Dr Joshua Bauml and Dr Joshua Sabari
WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC ( Dr Joshua Bauml and Dr Joshua Sabari )
3 Feb 2021

New data from rare EGFR alterations in NSCLC from WCLC 2020

Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong
New data from rare EGFR alterations in NSCLC from WCLC 2020 ( Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong )
2 Feb 2021

A new way of thinking on the origin of breast cancer and how early breast cancer should be treated

Prof László Tabár - University of Uppsala, Uppsala, Sweden
A new way of thinking on the origin of breast cancer and how early breast cancer should be treated ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )
29 Jan 2021

The history of breast cancer diagnosis

Prof László Tabár - University of Uppsala, Uppsala, Sweden
The history of breast cancer diagnosis ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )
29 Jan 2021

Recent therapies for HER2 advanced breast cancer

Dr Sandra Swain - Georgetown University, Washington DC, USA
Recent therapies for HER2 advanced breast cancer ( Dr Sandra Swain - Georgetown University, Washington DC, USA )
29 Jan 2021

BRCA mutation in metastatic TNBC patients

Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon
BRCA mutation in metastatic TNBC patients ( Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon )
28 Jan 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation